Skip to main content
. 2025 Feb 7;15(2):253. doi: 10.3390/life15020253
AMPK adenosine monophosphate-activated protein kinase
ASGR1 asialoglycoprotein receptor 1
CKM cardiovascular-kidney-metabolic
CVD cardiovascular disease
GLP-1RA glucagon-like peptide-1 receptor agonists
MR Mendelian randomization
mTOR mechanistic target of rapamycin
RCT randomized controlled trial
SGLT2 sodium–glucose cotransporter-2